RxE2 logo

RxE2 Funding & Investors

RxE2 is the first company to make decentralized clinical trials a cost-effective reality. By integrating the practice of pharmacy into every aspect of clinical trials, RxE2 empowers local pharmacists, as trusted medication experts, to use their extensive patient insights and make clinical trials more accessible to patients, everywhere. This, in turn, vastly reduces clinical trial timelines and costs, helps patients achieve better health outcomes, and provides study sponsors with more accurate data.

rx-e2.com

Total Amount Raised: $3,543,346

RxE2 Funding Rounds

  • Series Unknown

    $3,543,346

Funding info provided by Diffbot.